UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of Earliest Event Reported): March 29, 2010 (March 15,
2010)
PROTEIN
POLYMER TECHNOLOGIES, INC.
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
000-19724
|
33-0311631
|
||
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
11494
Sorrento Valley Road, San Diego, CA
|
92121
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
Telephone Number, Including Area Code: (858) 558-6064
Not
Applicable
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
1
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment
of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective
March 15, 2010, Richard Adelson resigned his position as a member of the Board
of Directors (the “Board”) of Protein Polymer Technologies, Inc. (the
“Company”). Such resignation includes his positions as a member of
both the Audit Committee and Compensation Committee of the Board of the
Company. Mr. Adelson’s resignation was not the result of any known
disagreement with the Company on any matter relating to the Company’s
operations, policies, or practices.
Effective
March 15, 2010, Allan Farber resigned his position as a member of the Board of
the Company. Such resignation includes his positions as a member of
both the Audit Committee and Compensation Committee of the Board of the
Company. Mr. Farber’s resignation was not the result of any known
disagreement with the Company on any matter relating to the Company’s
operations, policies, or practices.
Effective
March 15, 2010, Kerry L. Kuhn, M.D., resigned his position as a member of the
Board of the Company. Such resignation includes his position as a
member of the Compensation Committee of the Board of the Company. Dr.
Kuhn’s resignation was not the result of any known disagreement with the Company
on any matter relating to the Company’s operations, policies, or
practices.
The
Company has not yet identified suitable individuals to fill the Board seats
vacated by Mr. Adelson, Mr. Farber, and Dr. Kuhn.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
PROTEIN
POLYMER TECHNOLOGIES, INC.
|
||
Date: March
29, 2010
|
By:
|
/S/ JAMES
B. MCCARTHY
|
James
B. McCarthy
Interim
Chief Executive Officer
|
2